| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.35 | 4e-16 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-15 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.4 | 9e-15 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-13 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-13 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-13 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.35 | 5e-11 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.26 | 6e-10 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-09 |